Scienta adds Morgan to clinical team
Morgan will provide scientific advice and writing services during all stages of Scienta's CME planning process, as well as assist in designing outcome measurement tools for CME initiatives. Previously he was medical sciences editor at Education and Training Systems International.
Before that, Morgan designed experiments supporting the development of novel therapeutic agents that safely control disorders of blood coagulation and thrombosis at SmithKline Beecham Pharmaceuticals. He is a Harvard University graduate. He received his MD from Duke University and his MPH from George Washington University School of Public Health and Health Services.